Detection of recurrent prostate cancer after cryosurgery

Current Opinion in Urology

Volumn 8, Issue 2, 1998, Pages 83-86

  Parivar, Farhad ^a   Kurhanewicz, John ^b  

^a KAISER PERMANENTE MEDICAL CENTER   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

PROSTATE SPECIFIC ANTIGEN;

CRYOSURGERY; DIAGNOSTIC APPROACH ROUTE; HUMAN; PRIORITY JOURNAL; PROSTATE CANCER; RECURRENT CANCER; SHORT SURVEY;

EID: 0031885437     PISSN: 09630643     EISSN: None     Source Type: Journal    
DOI: 10.1097/00042307-199803000-00003     Document Type: Short Survey

References (15)

1. Goad JR, Chang SJ, Ohori M, Scardino PT. PSA after definitive radiotherapy for clinically localized prostate cancer. Urol Clin North Am 1993; 20:727-736.
2. Kavadi VS, Zagars GK, Pollack A. Serum prostate-specific antigen after radiation therapy for clinically localized prostate cancer: prognostic implications. Int J Radiat Oncol Biol Phys 1994; 30:279-287.
3. Geist RW. Reference range for prostate specific-antigen levels affer external beam radiation therapy for adenocarcinoma of prostate. Urology 1995; 45:1016-1021.
4. Shinohara K, Connolly JA, Presti Jr JC, Carroll PR. Cryosurgical treatment of prostate cancer (T1-T4): preliminary results. J Urol 1996; 156:115-121.
5. Grampsas SA, Miller GJ, Crawford ED. Salvage radical prostatectomy after failed transperineal cryotherapy: histologic findings from prostate whole-mount specimens correlated with intraoperative transrectal ultrasound images. Urology 1995; 45:936-941.
6. Kalbhen CL, Hricak H, Shinohara K, Chen M, Parivar F, Kurhanewicz J, et al. Prostate carcinoma: MR imaging findings after cryosurgery. Radiology 1996; 198:807-811.
7. Parivar F, Hricak H, Shinohara K, Kurhanewicz J, Vigneron DB, Nelson SJ, et al. Detection of locally recurrent prostate cancer after cryosurgery: evaluation by transrectal ultrasound, magnetic resonance imaging, and three-dimensional proton magnetic resonance spectroscopy. Urology 1996; 48:594-599. This is a prospective study comparing ultrasound, MRI and MRSI, demonstrating sensitivity and specificity of MRSI in a small number of patients.
8. Borkowski P, Robinson MJ, Poppiti RJ, Nash SC. Histologic findings in postcryosurgical prostatic biopsies. Mol Pathol 1996; 9:807-811.
9. Falconieri G, Lugnani F, Signoretto D, Di Bonito L. Histopathology of the frozen prostate. The microscopic bases of prostatic carcinoma cryoablation. Pathol Res Pract 1996; 192:579-587.
10. Shuman BA, Cohen JK, Miller Jr RJ, Rooker GM, Olson PR. Histological presence of viable prostatic glands on routine biopsy following cryosurgical ablation of the prostate. J Urol 1997; 157:552-555.
11. Connolly JA, Shinohara K, Presti Jr JC, Carroll PR. Prostate-specific antigen after cryosurgical ablation of the prostate. Urol Clin North Am 1997; 24:415-420. This is an excellent report of cryosurgery outcome from San Francisco with 2 year follow up compared with other reports in the literature.
12. Miller Jr RJ, Cohen JK, Meroltti LA. Percutaneous transperineal cryosurgical ablation of the prostate for the primary treatment of clinical stage C adenocarcinoma of the prostate. Urology 1994; 44:170-174.
13. Bahn DK, Lee F, Solomon MH, Contina H, Klionsky DL, Lee Jr FT, et al. Prostate cancer: US-guided percutaneous cryoablation. Radiology 1995; 194:551-556.
14. Kurhanewicz J, Vigneron DB, Hricak H, Narayan P, Carroll PR, Nelson SJ, et al. Three-dimensional H-1 MR spectroscopic imaging of the in situ human prostate with high (0.24-0.7 cm) spatial resolution. Radiology 1996; 198:795-805. This is a detailed description of methodology of three-dimensional MRSI and discrimination between cancer, benign tissue and necrosis.
15. Kurhanewicz J, Vigneron DB, Hricak H, Parivar F, Nelson SJ, Shinohara K, et al. Prostate cancer: metabolic response to cryosurgery as detected with 3D H-1 MR spectroscopic imaging. Radiology 1996; 200:489-496. A clinical study is presented of evaluation of patients with detectable PSA after cryosurgery by MRSI compared with prostate biopsy. Detailed methodology of MRSI is given.